TELADOC HEALTH, INC. Investment Income, Interest
TELADOC HEALTH, INC. (TDOC) reported Investment Income, Interest of $6.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-07-30
- TELADOC HEALTH, INC. investment income, interest for the quarter ending 2026-06-30 was $6.48M, a 35.60% decline year-over-year.
- TELADOC HEALTH, INC. investment income, interest for the quarter ending 2026-03-31 was $6.49M, a 48.79% decline year-over-year.
- TELADOC HEALTH, INC. investment income, interest for the quarter ending 2025-12-31 was $6.95M, a 51.16% decline year-over-year.
- TELADOC HEALTH, INC. investment income, interest for the quarter ending 2025-09-30 was $7.08M, a 53.80% decline year-over-year.
- TELADOC HEALTH, INC. investment income, interest for fiscal 2025 was $36.77M, a 35.57% decline from fiscal 2024.
- TELADOC HEALTH, INC. investment income, interest for fiscal 2024 was $57.07M, a 21.99% increase from fiscal 2023.
- TELADOC HEALTH, INC. investment income, interest for fiscal 2023 was $46.78M, a 269.12% increase from fiscal 2022.
- TELADOC HEALTH, INC. investment income, interest for fiscal 2022 was $12.67M, a 1533.25% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.48M 10-Q · filed 2026-07-30 | $12.97M 10-Q · filed 2026-07-30 | $19.92M derived: sum of 3 quarters · filed 2026-07-30 | $27.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $6.49M 10-Q · filed 2026-04-30 | $13.44M derived: sum of 2 quarters · filed 2026-04-30 | $20.52M derived: sum of 3 quarters · filed 2026-04-30 | $30.59M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.03M derived: sum of 2 quarters · filed 2026-02-26 | $24.10M derived: sum of 3 quarters · filed 2026-07-30 | $36.77M 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.08M 10-Q · filed 2025-10-30 | $17.14M derived: sum of 2 quarters · filed 2026-07-30 | $29.82M 10-Q · filed 2025-10-30 | $44.05M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $10.06M 10-Q · filed 2026-07-30 | $22.74M 10-Q · filed 2026-07-30 | $36.97M derived: sum of 3 quarters · filed 2026-07-30 | $52.30M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $12.67M 10-Q · filed 2026-04-30 | $26.91M derived: sum of 2 quarters · filed 2026-04-30 | $42.23M derived: sum of 3 quarters · filed 2026-04-30 | $55.80M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $14.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $29.56M derived: sum of 2 quarters · filed 2026-02-26 | $43.13M derived: sum of 3 quarters · filed 2026-02-26 | $57.07M 10-K · filed 2026-02-26 |
| 2024-09-30 | $15.33M 10-Q · filed 2025-10-30 | $28.90M derived: sum of 2 quarters · filed 2025-10-30 | $42.84M 10-Q · filed 2025-10-30 | $56.55M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $13.57M 10-Q · filed 2025-07-30 | $27.51M 10-Q · filed 2025-07-30 | $41.22M derived: sum of 3 quarters · filed 2026-02-26 | $53.83M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $13.94M 10-Q · filed 2025-05-01 | $27.65M derived: sum of 2 quarters · filed 2026-02-26 | $40.26M derived: sum of 3 quarters · filed 2026-02-26 | $51.81M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $13.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.31M derived: sum of 2 quarters · filed 2026-02-26 | $37.87M derived: sum of 3 quarters · filed 2026-02-26 | $46.78M 10-K · filed 2026-02-26 |
| 2023-09-30 | $12.61M 10-Q · filed 2024-10-31 | $24.16M derived: sum of 2 quarters · filed 2024-10-31 | $33.08M 10-Q · filed 2024-10-31 | $39.56M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $11.56M 10-Q · filed 2024-08-01 | $20.47M 10-Q · filed 2024-08-01 | $26.95M derived: sum of 3 quarters · filed 2025-02-27 | $31.75M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $8.91M 10-Q · filed 2024-04-26 | $15.39M derived: sum of 2 quarters · filed 2025-02-27 | $20.20M derived: sum of 3 quarters · filed 2025-02-27 | $21.42M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.29M derived: sum of 2 quarters · filed 2025-02-27 | $12.51M derived: sum of 3 quarters · filed 2025-02-27 | $12.67M 10-K · filed 2025-02-27 |
| 2022-09-30 | $4.80M 10-Q · filed 2023-10-27 | $6.03M derived: sum of 2 quarters · filed 2023-10-27 | $6.19M 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $1.23M 10-Q · filed 2023-07-28 | $1.39M 10-Q · filed 2023-07-28 | ||
| 2021-12-31 | $776.00K 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |